Human T cell aging and the impact of persistent viral infections

Frontiers in Immunology

Volumn 4, Issue SEP, 2013, Pages

  Fulop T ^a   Larbi, A ^b   Pawelec, G ^c  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b AGENCY FOR SCIENCE   (Singapore)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Aging; Chronic stimulation; CMV; Immunosenescence; T cells

Indexed keywords

C REACTIVE PROTEIN; CD137 LIGAND; CD27 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7; L SELECTIN; MAMMALIAN TARGET OF RAPAMYCIN; OX40 LIGAND; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; CD8+ T LYMPHOCYTE; CELL AGING; CELL DIFFERENTIATION; CELL POPULATION; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS INFECTION; HUMAN; IMMUNE SYSTEM; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; PERSISTENT VIRUS INFECTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 84886033654     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00271     Document Type: Review

References (100)

1. Effros RB. Telomere/telomerase dynamics within the human immune system: effect of chronic infection and stress. Exp Gerontol (2011) 46:135-40. doi:10.1016/j.exger.2010.08.027.
2. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol (2004) 5:133-9. doi:10.1038/ni1033.
3. Agrawal A, Gupta S. Impact of aging on dendritic cell functions in humans. Ageing Res Rev (2011) 10:336-45. doi:10.1016/j.arr.2010.06.004.
4. Fülöp T, Fortin C, Lesur O, Dupuis G, Kotb JR, Lord JM, et al. The innate immune system and aging: what is the contribution to immunosenescence? Open Longevity Science (2012) 6:121-32. doi:10.2174/1876326X01206010121.
5. Camous X, Pera A, Solana R, Larbi A. NK cells in healthy aging and age-associated diseases. J Biomed Biotechnol (2012) 2012:195956. doi:10.1155/2012/195956.
6. Daley-Bauer LP, Wynn GM, Mocarski ES. Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes. Immunity (2012) 37:122-33. doi:10.1016/j.immuni.2012.04.014.
7. Larbi A, Rymkiewicz P, Asudev A, Low I, Shadan BN, Mustafah S, et al. The immune system in the elderly: a fair fight against diseases. Aging Health (2013) 9:1-13. doi:10.2217/ahe.12.78.
8. Pawelec G. Hallmarks of human "immunosenescence" adaptation or dysregulation? Immunol Ageing (2012) 9:15. doi:10.1186/1742-4933-9-15.
9. Fülöp T, Le Page A, Garneau H, Azimi N, Baehl S, Dupuis G, et al. Aging, immunosenescence and membrane rafts: the lipid connection. Longevity Healthspan (2012) 1:6. doi:10.1186/2046-2395-1-6.
10. Solana R, Tarazona R, Inmaculada G, Lesur O, Dupuis G, Fülöp T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol (2012) 24:331-41. doi:10.1016/j.smim.2012.04.008.
11. Kober J, Leitner J, Klauserm C, Woitekm R, Majdicm O, Stöcklm J, et al. The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells. Eur J Immunol (2008) 38:2678-88. doi:10.1002/eji.200838250.
12. Chiu WK, Fann M, Weng NP. Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines. J Immunol (2006) 177:7802-10.
13. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci (2000) 908:244-54. doi:10.1111/j.1749-6632.2000.tb06651.x.
14. Le Saux S, Weyand CM, Goronzy JJ. Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann N Y Acad Sci (2012) 1247:69-82. doi:10.1111/j.1749-6632.2011.06297.x.
15. Aspinall R, Andrew D. Thymic involution in aging. J Clin Immunol (2000) 20:250-6. doi:10.1023/A:1006611518223.
16. Spielmann G, McFarlin BK, O'Connor DP, Smith PJ, Pircher H, Simpson RJ. Aerobic fitness is associated with lower proportions of senescent blood T-cells in man. Brain Behav Immun (2011) 25:1521-9. doi:10.1016/j.bbi.2011.07.226.
17. Weinberger B, Lazuardi L, Weiskirchner I, Keller M, Neuner C, Fischer KH, et al. Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol (2007) 68:86-90. doi:10.1016/j.humimm.2006.10.019.
18. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol (2004) 22:745-63. doi:10.1146/annurev.immunol.22.012703.104702.
19. Surh CD, Sprent J. Homeostasis of naive and memory T cells. Immunity (2008) 29:848-62. doi:10.1016/j.immuni.2008.11.002.
20. Nikolich-Zugich J. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol (2008) 8:512-22. doi:10.1038/nri2318.
21. Saule P, Trauet J, Dutriez V, Lekeux V, Dessaint JP, Labalette M. Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment. Mech Ageing Dev (2006) 127:274-81. doi:10.1016/j.mad.2005.11.001.
22. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res (1961) 25:585-621. doi:10.1016/0014-4827(61)90192-6.
23. Di Mitri D, Azevedo RI, Henson SM, Libri V, Riddell NE, Macaulay R, et al. Reversible senescence in human CD4+CD45RA+CD27-memory T cells. J Immunol (2011) 187:2093-100. doi:10.4049/jimmunol.1100978.
24. Henson SM, Riddell NE, Akbar AN. Properties of end-stage human T cells defined by CD45RA re-expression. Curr Opin Immunol (2012) 24:476-81. doi:10.1016/j.coi.2012.04.001.
25. Lazuardi L, Herndler-Brandstetter D, Brunner S, Laschober GT, Lepperdinger G, Grubeck-Loebenstein B. Microarray analysis reveals similarity between CD8+CD28-T cells from young and elderly persons, but not of CD8+CD28+ T cells. Biogerontology (2009) 10:191-202. doi:10.1007/s10522-008-9167-1.
26. Henson SM, Franzese O, Macaulay R, Libri V, Azevedo RI, Kiani-Alikhan S, et al. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood (2009) 113:6619-28. doi:10.1182/blood-2009-01-199588.
27. Akbar AN, Henson SM. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat Rev Immunol (2011) 11(4):289-95. doi:10.1038/nri2959.
28. Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson BO, Ferguson FG. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev (2000) 121:187-201. doi:10.1016/S0047-6374(00)00210-4.
29. Wikby A, Ferguson F, Forsey R, Thompson J, Strindhall J, Löfgren S, et al. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci (2005) 60:556-65. doi:10.1093/gerona/60.5.556.
30. Hadrup SR, Strindhall J, Køllgaard T, Seremet T, Johansson B, Pawelec G, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol (2006) 176:2645-53.
31. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy." J Exp Med (1994) 179:609-18. doi:10.1084/jem.179.2.609.
32. Callahan JE, Kappler JW, Marrack P. Unexpected expansions of CD8-bearing cells in old mice. J Immunol (1993) 151:6657-69.
33. Naylor K, Li G, Vallejo AN, Lee WW, Koetz K, Bryl E, et al. The influence of age on T cell generation and TCR diversity. J Immunol (2005) 174:7446-52.
34. Khan N, ShariffN, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol (2002) 169:1984-92.
35. Appay V, Rowland-Jones SL. Lessons from the study of T-cell differentiation in persistent human virus infection. Semin Immunol (2004) 16:205-12. doi:10.1016/j.smim.2004.02.007.
36. Wikby A, Nilsson BO, Forsey R, Thompson J, Strindhall J, Löfgren S, et al. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev (2006) 127:695-704. doi:10.1016/j.mad.2006.04.003.
37. Strindhall J, Nilsson BO, Löfgren S, Ernerudh J, Pawelec G, Johansson B, et al. No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp Gerontol (2007) 42:753-61. doi:10.1016/j.exger.2007.05.001.
38. Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS ONE (2011) 6(2):e16103. doi:10.1371/journal.pone.0016103.
39. Pawelec G, McElhaney JE, Aiello AE, Derhovanessian E. The impact of CMV infection on survival in older humans. Curr Opin Immunol (2012) 24:507-11. doi:10.1016/j.coi.2012.04.002.
40. Bartlett DB, Firth CM, Phillips AC, Moss P, Baylis D, Syddall H, et al. The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection. Aging Cell (2012) 11:912-5. doi:10.1111/j.1474-9726.2012.00849.x.
41. Vescovini R, Biasini C, Telera AR, Basaglia M, Stella A, Magalini F, et al. Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. J Immunol (2010) 184:3242-9. doi:10.4049/jimmunol.0902890.
42. Plonquet A, Bastuji-Garin S, Tahmaseb F, Brisacier C, Ledudal K, Farcet J, et al. Immune risk phenotype is associated with nosocomial lung infections in elderly in-patients. Immun Ageing (2011) 8:8. doi:10.1186/1742-4933-8-8.
43. Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med (2005) 202:673-85. doi:10.1084/jem.20050882.
44. Boldogh I, Albrecht T, Porter DD. Persistent Viral Infections. 4th ed. In: Baron S editor. Medical Microbiology. Galveston, TX: University of Texas Medical Branch at Galveston (1996).
45. Lemmermann NA, Böhm V, Holtappels R, Reddehase MJ. In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: facts and thoughts based on murine models. Virus Res (2011) 157:161-74. doi:10.1016/j.virusres.2010.09.022.
46. Gayoso I, Cantisán S, Cerrato C, Sánchez-García J, Martin C, Solana R, et al. Clinical factors influencing phenotype of HCMV-specific CD8+ T cells and HCMV-induced interferon-gamma production after allogeneic stem cells transplantation. Clin Dev Immunol (2013) 2013:347213. doi:10.1155/2013/347213.
47. Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M. The pathogenesis of Epstein-Barr virus persistent infection. Curr Opin Virol (2013) 3(3):227-32. doi:10.1016/j.coviro.2013.04.005.
48. Brunner S, Herndler-Brandstetter D, Weinberger B, Grubeck-Loebenstein B. Persistent viral infections and immune aging. Ageing Res Rev (2011) 10:362-9. doi:10.1016/j.arr.2010.08.003.
49. Theiler RN, Farr SL, Karon JM, Paramsothy P, Viscidi R, Duerr A, et al. High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol (2010) 115:1150-8. doi:10.1097/AOG.0b013e3181e00927.
50. LegoffJ, Amiel C, Calisonni O, Fromentin D, Rajoely B, Abuaf N, et al. Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection. J Clin Immunol (2004) 24:125-34. doi:10.1023/B:JOCI.0000019777.75784.6f.
51. van der Burg SH, Arens R, Melief CJ. Immunotherapy for persistent viral infections and associated disease. Trends Immunol (2011) 32:97-103. doi:10.1016/j.it.2010.12.006.
52. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med (2002) 8:379-85. doi:10.1038/nm0402-379.
53. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med (2011) 62:141-55. doi:10.1146/annurev-med-042909-093756.
54. Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G, et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol (2001) 75:5550-8. doi:10.1128/JVI.75.12.5550-5558.2001.
55. Almanzar G, Schwaiger S, Jenewein B, Keller M, Herndler-Brandstetter D, Würzner R, et al. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol (2005) 79:3675-83. doi:10.1128/JVI.79.6.3675-3683.2005.
56. Derhovanessian E, Maier AB, Beck R, Jahn G, Hähnel K, Slagboom PE, et al. Hallmark features of immunosenescence are absent in familial longevity. J Immunol (2010) 185:4618-24. doi:10.4049/jimmunol.1001629.
57. Derhovanessian E, Maier AB, Hähnel K, Beck R, de Craen AJ, Slagboom EP, et al. Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol (2011) 92:2746-56. doi:10.1099/vir.0.036004-0.
58. Méndez-Lagares G, Díaz L, Correa-Rocha R, León Leal JA, Ferrando-Martínez S, Ruiz-Mateos E, et al. Specific patterns of CD41-associated immunosenescence in vertically HIV-infected subjects. Clin Microbiol Infect (2013) 19(6):558-65. doi:10.1111/j.1469-0691.2012.03934.x.
59. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol (2008) 214:231-41. doi:10.1002/path.2276.
60. Ipp H, Zemlin A. The paradox of the immune response in HIV infection: when inflammation becomes harmful. Clin Chim Acta (2013) 416:96-9. doi:10.1016/j.cca.2012.11.025.
61. Fulop T, Larbi A, Kotb R, de Angelis F, Pawelec G. Aging, immunity, and cancer. Discov Med (2011) 11:537-50.
62. Characiejus D, Pasukoniene V, Kazlauskaite N, Valuckas KP, Petraitis T, Mauricas M, et al. Predictive value of CD8highCD57+ lymphocyte subset in interferon therapy of patients with renal cell carcinoma. Anticancer Res (2002) 22:3679-83.
63. Tsukishiro T, Donnenberg AD, Whiteside TL. Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer. Cancer Immunol Immunother (2003) 52:599-607. doi:10.1007/s00262-003-0395-6.
64. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med (2006) 12:1365-71. doi:10.1038/nm1511.
65. Larbi A, Pawelec G, Witkowski JM, Schipper HM, Derhovanessian E, Goldeck D, et al. Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease. J Alzheimers Dis (2009) 17:91-103. doi:10.3233/JAD-2009-1015.
66. Buchholz VR, Neuenhahn M, Busch DH. CD8+ T cell differentiation in the aging immune system: until the last clone standing. Curr Opin Immunol (2011) 23:549-54. doi:10.1016/j.coi.2011.05.002.
67. Carvalheiro H, da Silva JA, Souto-Carneiro MM. Potential roles for CD8(+) T cells in rheumatoid arthritis. Autoimmun Rev (2013) 12:401-9. doi:10.1016/j.
68. Chidrawar S, Khan N, Wei W, McLarnon A, Smith N, Nayak L, et al. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol (2009) 155:423-32. doi:10.1111/j.1365-2249.2008.03785.x.
69. Karrer U, Mekker A, Wanke K, Tchang V, Haeberli L. Cytomegalovirus and immune senescence: culprit or innocent bystander? Exp Gerontol (2009) 44:689-94. doi:10.1016/j.exger.2009.09.003.
70. Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski UH, et al. Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol (2003) 170:2022-9.
71. Snyder CM, Cho KS, Bonnett EL, van Dommelen S, Shellam GR, Hill AB. Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity (2008) 29:650-9. doi:10.1016/j.immuni.2008.07.017.
72. Pourgheysari B, Khan N, Best D, Bruton R, Nayak L, Moss PA. The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol (2007) 81:7759-65. doi:10.1128/JVI.01262-06.
73. Wills M, Akbar A, Beswick M, Bosch JA, Caruso C, Colonna-Romano G, et al. Report from the second cytomegalovirus and immunosenescence workshop. Immunity & Ageing (2011) 8:10. doi:10.1186/1742-4933-8-10.
74. Solana R, Tarazona R, Aiello AE, Akbar AN, Appay V, Beswick M, et al. CMV and Immunosenescence: from basics to clinics. Immun Ageing (2012) 9(1):23. doi:10.1186/1742-4933-9-23.
75. Cantisán S, Torre-Cisneros J, Lara R, Zarraga S, Montejo M, Solana R. Impact of cytomegalovirus on early immunosenescence of CD8+ T lymphocytes after solid organ transplantation. J Gerontol A Biol Sci Med Sci (2013) 68:1-5. doi:10.1093/gerona/gls130.
76. Cicin-Sain L, Brien JD, Uhrlaub JL, Drabig A, Marandu TF, Nikolich-Zugich J. Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging. PLoS Pathog (2012) 8:e1002849. doi:10.1371/journal.ppat.1002849.
77. Mekker A, Tchang VS, Haeberli L, Oxenius A, Trkola A, Karrer U. Immune senescence: relative contributions of age and cytomegalovirus infection. PLoS Pathog (2012) 8:e1002850. doi:10.1371/journal.ppat.1002850.
78. Fletcher JM, Vukmanovic-Stejic M, Dunne PJ, Birch KE, Cook JE, Jackson SE, et al. Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol (2005) 175:8218-25.
79. Waller EC, McKinney N, Hicks R, Carmichael AJ, Sissons JG, Wills MR. Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28(-) CD45RA(HI)) CD8(+) T cells. Blood (2007) 110:4360-6. doi:10.1182/blood-2007-07-104604.
80. Ouyang Q, Wagner WM, Zheng W, Wikby A, Remarque EJ, Pawelec G. Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp Gerontol (2004) 39:607-13. doi:10.1016/j.exger.2003.11.016.
81. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev (2009) 8:18-30. doi:10.1016/j.arr.2008.07.002.
82. MacAulay R, Akbar AN, Henson SM. The role of the T cell in age-related inflammation. Age (Dordr) (2013) 35(3):563-72. doi:10.1007/s11357-012-9381-2.
83. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol (2013) 75:685-705. doi:10.1146/annurev-physiol-030212-183653.
84. Alves NL, Arosa FA, van Lier RA. IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells. J Immunol (2005) 175:755-62.
85. Nguyen H, Weng NP. IL-21 preferentially enhances IL-15-mediated homeostatic proliferation of human CD28+ CD8 memory T cells throughout the adult age span. J Leukoc Biol (2010) 87:43-9. doi:10.1189/jlb.0209086.
86. Brennan DC, Aguado JM, Potena L, Jardine AG, Legendre C, Säemann MD, et al. Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms. Rev Med Virol (2013) 23:97-125. doi:10.1002/rmv.1733.
87. Poglitsch M, Weichhart T, Hecking M, Werzowa J, Katholnig K, Antlanger M, et al. CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages. Am J Transplant (2012) 12:1458-68. doi:10.1111/j.1600-6143.2012.04002.x.
88. Xu X, Ye L, Araki K, Ahmed R. mTOR, linking metabolism and immunity. Sem Immunol (2012) 24:429-35. doi:10.1016/j.smim.2012.12.005.
89. Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol (2007) 42:563-70. doi:10.1016/j.exger.2007.01.005.
90. McElhaney JE, Zhou X, Talbot HK, Soethout E, Bleackley RC, Granville DJ, et al. The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine (2012) 30:2060-7. doi:10.1016/j.vaccine.2012.01.015.
91. Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Weyand CM. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 75:12182-7. doi:10.1128/JVI.75.24.12182-12187.2001.
92. Trzonkowski P, Mysliwska J, Szmit E, Wieckiewicz J, Lukaszuk K, Brydak LB, et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination-an impact of immunosenescence. Vaccine (2003) 21:3826-36. doi:10.1016/S0264-410X(03)00309-8.
93. Saurwein-Teissl M, Lung TL, Marx F, Gschosser C, Asch E, Blasko I, et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol (2002) 168(11):5893-9.
94. Moro-García MA, Alonso-Arias R, López-Vázquez A, Suárez-García FM, Solano-Jaurrieta JJ, Baltar J, et al. Relationship between functional ability in older people, immune system status, and intensity of response to CMV. Age (Dordr) (2012) 34:479-95. doi:10.1007/s11357-011-9240-6.
95. Derhovanessian E, Theeten H, Hähnel K, Van Damme P, Cools N, Pawelec G. Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine (2013) 31:685-90. doi:10.1016/j.vaccine.2012.11.041.
96. den Elzen WP, Vossen AC, Cools HJ, Westendorp RG, Kroes AC, Gussekloo J. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine (2011) 29:4869-74. doi:10.1016/j.vaccine.2011.03.086.
97. Blankenberg S, Rupprecht HJ, Bickel C, Espinola-Klein C, Rippin G, Hafner G, et al. Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation (2001) 103:2915-21. doi:10.1161/01.CIR.103.24.2915.
98. Bentz GL, Yurochko AD. Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins. Proc Natl Acad Sci U S A (2008) 105:5531-6. doi:10.1073/pnas.0800037105.
99. Chen S, de Craen AJ, Raz Y, Derhovanessian E, Vossen AC, Westendorp RG, et al. Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus Study. Immun Ageing (2012) 9:18. doi:10.1186/1742-4933-9-18.
100. Leng SX, Qu T, Semba RD, Li H, Yao X, Nilles T, et al. Relationship between cytomegalovirus (CMV) IgG serology, detectable CMV DNA in peripheral monocytes, and CMV pp65(495-503)-specific CD8+ T cells in older adults. Age (Dordr) (2011) 33:607-14. doi:10.1007/s11357-011-9205-9.